Pfizer Net Long-Term Debt 2010-2025 | PFE

Pfizer net long-term debt for the twelve months ending June 30, 2025 was $-4.563B, a 108.61% decline year-over-year.

  • Pfizer annual net long-term debt for 2024 was $-2.25B, a 107.96% decline from 2023.
  • Pfizer annual net long-term debt for 2023 was $28.262B, a 956.94% decline from 2022.
  • Pfizer annual net long-term debt for 2022 was $-3.298B, a 227.51% increase from 2021.

Pfizer Net Long-Term Debt 2010-2025 | PFE

  • Pfizer annual net long-term debt for 2024 was $-2.25B, a 107.96% decline from 2023.
  • Pfizer annual net long-term debt for 2023 was $28.262B, a 956.94% decline from 2022.
  • Pfizer annual net long-term debt for 2022 was $-3.298B, a 227.51% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$696.6B
Johnson & Johnson (JNJ)$425B
AbbVie (ABBV)$368.1B
Novartis AG (NVS)$267.5B
Roche Holding AG (RHHBY)$256.8B
Novo Nordisk (NVO)$247.1B
Merck (MRK)$212.3B
Sanofi (SNY)$123.5B
Bayer (BAYRY)$32.6B
Innoviva (INVA)$1.3B